Replimune Group logo

Replimune Group Share Price Today

(NASDAQ: REPL)

Replimune Group share price is $14.01 & ₹1,220.20 as on 5 Feb 2025, 2.30 'hrs' IST

$14.01

▲

0.3

(2.19%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Replimune Group share price in Dollar and Rupees. Guide to invest in Replimune Group stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Replimune Group, along with analyst recommendations, forecasts, and comprehensive financials.

Replimune Group share price movements

  • Today's Low: $13.46
    Today's High: $14.12

    Day's Volatility :4.64%

  • 52 Weeks Low: $4.92
    52 Weeks High: $17.00

    52 Weeks Volatility :71.06%

Replimune Group (REPL) Returns

PeriodReplimune Group IncS&P BSE IndustrialsNifty Smallcap 250
3 Months
10.31%
-10.8%
-10.4%
6 Months
52.28%
-13.0%
-6.4%
1 Year
83.14%
10.8%
4.5%
3 Years
-25.36%
125.8%
58.7%

Replimune Group (REPL) Key Statistics

in dollars & INR

Previous Close
$13.71
Open
$13.65
Today's High
$14.115
Today's Low
$13.46
Market Capitalization
$1.1B
Today's Volume
$404.7K
52 Week High
$17.0
52 Week Low
$4.92
Revenue TTM
$0.0
EBITDA
$-226.7M
Earnings Per Share (EPS)
$-3.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-50.32%

How to invest in Replimune Group Stock (REPL) from India?

It is very easy for Indian residents to invest directly in Replimune Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Replimune Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Replimune Group or REPL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Replimune Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Replimune Group shares which would translate to 0.062 fractional shares of Replimune Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Replimune Group, in just a few clicks!

Returns in Replimune Group (REPL) for Indian investors in Rupees

The Replimune Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Replimune Group investment value today

Current value as on today

₹1,88,041

Returns

₹88,041

(+88.04%)

Returns from Replimune Group Stock

₹83,137 (+83.14%)

Dollar Returns

₹4,903 (+4.9%)

Indian investors sentiment towards Replimune Group (REPL)

20%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Replimune Group Stock from India on INDmoney has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Replimune Group

  • Baker Bros Advisors LP

    14.35%

  • T. Rowe Price Associates, Inc.

    12.84%

  • BlackRock Inc

    7.11%

  • FCPM III SERVICES BV

    6.32%

  • Redmile Group, LLC

    6.21%

  • Vanguard Group Inc

    4.50%

Analyst Recommendation on Replimune Group

Buy

    93%Buy

    6%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Replimune Group(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Replimune Group Stock (REPL)

What analysts predicted

Upside of 42.76%

Target:

$20.00

Current:

$14.01

Insights on Replimune Group Stock (Ticker Symbol: REPL)

  • Price Movement

    In the last 3 months, REPL stock has moved up by 43.6%

  • Price Movement

    In the last 1 year, REPL stock has moved up by 98.7%

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 19.35 Cr → 20.54 Cr (in ₹), with an average increase of 5.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 2.64 Cr → 3.97 Cr (in ₹), with an average increase of 33.5% per quarter

  • REPL vs One 97 Communications Ltd (1 yr)

    In the last 1 year, One 97 Communications Ltd has given 78.3% return, outperforming this stock by 32.0%

  • REPL vs Firstsource Solutions Ltd (3 yr)

    In the last 3 years, Firstsource Solutions Ltd has given 128.8% return, outperforming this stock by 103.9%

  • REPL vs Firstsource Solutions Ltd (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 86.4% return, outperforming this stock by 109.7%

Replimune Group Technicals Summary

Sell

Neutral

Buy

Replimune Group is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Replimune Group (REPL) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Replimune Group Inc logo
Replimune Group Inc
16.56%
52.28%
83.14%
-25.36%
-16.36%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Replimune Group Inc logo
Replimune Group Inc
NA
NA
NA
-2.66
-0.5
-0.27
NA
5.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Replimune Group Inc logo
Replimune Group Inc
Buy
$1.1B
-16.36%
NA
0.0%

About Replimune Group

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
Organization
Replimune Group
Employees
331
CEO
Mr. Philip Astley-Sparke F.S.A.
Industry
Health Technology

Management People of Replimune Group

NameTitle
Mr. Philip Astley-Sparke F.S.A.
Executive Chairman
Ms. Emily Luisa Hill
Chief Financial Officer
Dr. Konstantinos Xynos M.B.A., M.D., Ph.D.
Chief Medical Officer
Dr. Sushil Patel Ph.D.
CEO & Director
Dr. Robert Coffin Ph.D.
Founder, Chief Scientist & Director
Mr. Andrew Schwendenman
Chief Accounting Officer & Treasurer
Mr. Christopher Sarchi
Chief Commercial Officer
Mr. Paul Bullock
Chief Manufacturing Officer & Framingham Site Head

Important FAQs about investing in REPL Stock from India :

What is Replimune Group share price today?

Replimune Group share price today stands at $14.01, Open: $13.65 ; Previous Close: $13.71 ; High: $14.12 ; Low: $13.46 ; 52 Week High: $17.00 ; 52 Week Low: $4.92.

The stock opens at $13.65, after a previous close of $13.71. The stock reached a daily high of $14.12 and a low of $13.46, with a 52-week high of $17.00 and a 52-week low of $4.92.

Can Indians buy Replimune Group shares?

Yes, Indians can invest in the Replimune Group (REPL) from India.

With INDmoney, you can buy Replimune Group at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Replimune Group at zero transaction cost.

How can I buy Replimune Group shares from India?

It is very easy to buy Replimune Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Replimune Group (REPL) be purchased?

Yes, you can buy fractional shares of Replimune Group with INDmoney app.

What are the documents required to start investing in Replimune Group stocks?

To start investing in Replimune Group, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Replimune Group Stock (REPL)?

Today’s highest price of Replimune Group (REPL) is $14.12.

Today’s lowest price of Replimune Group (REPL) is $13.46.

What is today's market capitalisation of Replimune Group?

Today's market capitalisation of Replimune Group REPL is 1.1B

What is the 52 Week High and Low Range of Replimune Group Stock (REPL)?

  • 52 Week High

    $17.00

  • 52 Week Low

    $4.92

What are the historical returns of Replimune Group (REPL)?

  • 1 Month Returns

    16.56%

  • 3 Months Returns

    52.28%

  • 1 Year Returns

    83.14%

  • 5 Years Returns

    -16.36%

Who is the Chief Executive Officer (CEO) of Replimune Group ?

Mr. Philip Astley-Sparke F.S.A. is the current Chief Executive Officer (CEO) of Replimune Group.